An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (26) , 11938-11949
Abstract
Background: Immune cells have essential auxiliary functions and influence clinical outcomes in cancer, with high immune infiltration being associated with improved clinical outcomes and better response to treatment in breast cancer (BC). However, studies to date have not fully considered the tumor-infiltrating immune cell (TIIC) landscape in tumors. This study investigated potential biomarkers based on TIICs to improve prognosis and treatment effect in BC.Keywords
This publication has 57 references indexed in Scilit:
- Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I–III Breast CancerJournal of the National Comprehensive Cancer Network, 2019
- Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell CarcinomaEuropean Urology, 2018
- Expression of programmed death ligand-1 and programmed death-1 in samples of invasive ductal carcinoma of the breast and its correlation with prognosisAnti-Cancer Drugs, 2018
- Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder CancerClinical Cancer Research, 2018
- Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast CancerAnnals of Surgical Oncology, 2018
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective StudyPLOS Medicine, 2016
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199Journal of Clinical Oncology, 2014
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- Tumour-infiltrating macrophages and clinical outcome in breast cancerJournal of Clinical Pathology, 2011